Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cipher Pharmaceuticals Inc (CPH.TO)

Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 364,637
  • Shares Outstanding, K 25,589
  • Annual Sales, $ 21,162 K
  • Annual Income, $ 20,383 K
  • 60-Month Beta 0.96
  • Price/Sales 11.82
  • Price/Cash Flow 15.36
  • Price/Book 3.03
Trade CPH.TO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.25
  • Number of Estimates 1
  • High Estimate 0.25
  • Low Estimate 0.25
  • Prior Year 0.36
  • Growth Rate Est. (year over year) -30.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.52 +15.28%
on 09/13/24
19.69 -32.55%
on 08/29/24
-3.68 (-21.70%)
since 08/26/24
3-Month
8.01 +65.79%
on 07/04/24
19.69 -32.55%
on 08/29/24
+4.85 (+57.53%)
since 06/26/24
52-Week
4.10 +223.90%
on 10/13/23
19.69 -32.55%
on 08/29/24
+8.96 (+207.41%)
since 09/26/23

Most Recent Stories

More News
Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg Pharma AB ("Moberg"), issued...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Reports Second Quarter 2024 Results

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the three and...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Stocks in play: Cipher Pharmaceuticals Inc.

Announces the signing of a definitive asset purchase agreement with ParaPRO LLC and the closing of the ...

CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announces the signing of a definitive asset purchase agreement with...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it held its annual and special meeting of...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Reports First Quarter 2024 Results

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the three...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Stocks in play: Cipher Pharmaceuticals Inc.

Will release its financial results for the first quarter of 2024 after the market close on Thursday, ...

CPH.TO : 13.28 (-6.81%)
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the...

CPHRF : 9.8875 (-6.70%)
CPH.TO : 13.28 (-6.81%)
Stocks in play: Cipher Pharmaceuticals

Will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take ...

CPH.TO : 13.28 (-6.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

See More

Key Turning Points

3rd Resistance Point 15.30
2nd Resistance Point 14.79
1st Resistance Point 14.04
Last Price 13.28
1st Support Level 12.78
2nd Support Level 12.27
3rd Support Level 11.52

See More

52-Week High 19.69
Fibonacci 61.8% 13.73
Last Price 13.28
Fibonacci 50% 11.90
Fibonacci 38.2% 10.06
52-Week Low 4.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar